125 related articles for article (PubMed ID: 8902098)
1. Cutaneous histopathologic features in weanling pigs after exposure to three different doses of liquid sulfur mustard.
Smith KJ; Skelton HG; Hobson DW; Reid FM; Blank JA; Hurst CG
Am J Dermatopathol; 1996 Oct; 18(5):515-20. PubMed ID: 8902098
[TBL] [Abstract][Full Text] [Related]
2. Histopathologic features seen with different animal models following cutaneous sulfur mustard exposure.
Smith KJ; Casillas R; Graham J; Skelton HG; Stemler F; Hackley BE
J Dermatol Sci; 1997 Feb; 14(2):126-35. PubMed ID: 9039976
[TBL] [Abstract][Full Text] [Related]
3. Medical management of cutaneous sulfur mustard injuries.
Graham JS; Stevenson RS; Mitcheltree LW; Hamilton TA; Deckert RR; Lee RB; Schiavetta AM
Toxicology; 2009 Sep; 263(1):47-58. PubMed ID: 18762227
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical studies of basement membrane proteins and proliferation and apoptosis markers in sulfur mustard induced cutaneous lesions in weanling pigs.
Smith KJ; Graham JS; Hamilton TA; Skelton HG; Petrali JP; Hurst CG
J Dermatol Sci; 1997 Sep; 15(3):173-82. PubMed ID: 9302645
[TBL] [Abstract][Full Text] [Related]
5. CO2 laser debridement of sulphur mustard (bis-2-chloroethyl sulphide) induced cutaneous lesions accelerates production of a normal epidermis with elimination of cytological atypia.
Smith KJ; Skelton HG; Martin JL; Hurst CG; Hackley BE
Br J Dermatol; 1997 Oct; 137(4):590-4. PubMed ID: 9390337
[TBL] [Abstract][Full Text] [Related]
6. Treatment of skin injuries induced by sulfur mustard with calmodulin antagonists, using the pig model.
Kadar T; Fishbeine E; Meshulam Y; Sahar R; Chapman S; Liani H; Barness I; Amir A
J Appl Toxicol; 2000 Dec; 20 Suppl 1():S133-6. PubMed ID: 11428625
[TBL] [Abstract][Full Text] [Related]
7. A cutaneous full-thickness liquid sulfur mustard burn model in weanling swine: clinical pathology and urinary excretion of thiodiglycol.
Graham JS; Reid FM; Smith JR; Stotts RR; Tucker ES; Shumaker SM; Niemuth NA; Janny SJ
J Appl Toxicol; 2000 Dec; 20 Suppl 1():S161-72. PubMed ID: 11428630
[TBL] [Abstract][Full Text] [Related]
8. Selection of non-steroidal anti-inflammatory drug and treatment regimen for sulfur mustard-induced cutaneous lesions.
Plahovinsak JL; Buccellato MA; Reid FM; Graham JS
Cutan Ocul Toxicol; 2016 Sep; 35(3):208-17. PubMed ID: 26362124
[TBL] [Abstract][Full Text] [Related]
9. Detection and measurement of sulfur mustard offgassing from the weanling pig following exposure to saturated sulfur mustard vapor.
Logan TP; Graham JS; Martin JL; Zallnick JE; Jakubowski EM; Braue EH
J Appl Toxicol; 2000 Dec; 20 Suppl 1():S199-204. PubMed ID: 11428637
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effects of cooling swine skin exposed to sulfur mustard.
Sawyer TW; Nelson P; Hill I; Conley JD; Blohm K; Davidson C; Sawyer TW
Mil Med; 2002 Nov; 167(11):939-43. PubMed ID: 12448623
[TBL] [Abstract][Full Text] [Related]
11. Histopathologic features seen in sulfur mustard induced cutaneous lesions in hairless guinea pigs.
Smith KJ; Graham JS; Moeller RB; Okerberg CV; Skelton H; Hurst CG
J Cutan Pathol; 1995 Jun; 22(3):260-8. PubMed ID: 7593821
[TBL] [Abstract][Full Text] [Related]
12. Histopathologic and immunohistochemical features in human skin after exposure to nitrogen and sulfur mustard.
Smith KJ; Smith WJ; Hamilton T; Skelton HG; Graham JS; Okerberg C; Moeller R; Hackley BE
Am J Dermatopathol; 1998 Feb; 20(1):22-8. PubMed ID: 9504665
[TBL] [Abstract][Full Text] [Related]
13. Topical iodine preparation as therapy against sulfur mustard-induced skin lesions.
Wormser U; Sintov A; Brodsky B; Nyska A
Toxicol Appl Pharmacol; 2000 Nov; 169(1):33-9. PubMed ID: 11076694
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic approaches to dermatotoxicity by sulfur mustard. I. Modulaton of sulfur mustard-induced cutaneous injury in the mouse ear vesicant model.
Casillas RP; Kiser RC; Truxall JA; Singer AW; Shumaker SM; Niemuth NA; Ricketts KM; Mitcheltree LW; Castrejon LR; Blank JA
J Appl Toxicol; 2000 Dec; 20 Suppl 1():S145-51. PubMed ID: 11428628
[TBL] [Abstract][Full Text] [Related]
15. Toxicology and pharmacology of the chemical warfare agent sulfur mustard.
Dacre JC; Goldman M
Pharmacol Rev; 1996 Jun; 48(2):289-326. PubMed ID: 8804107
[TBL] [Abstract][Full Text] [Related]
16. The role of interleukin-6 (IL-6) in human sulfur mustard (HD) toxicology.
Arroyo CM; Broomfield CA; Hackley BE
Int J Toxicol; 2001; 20(5):281-96. PubMed ID: 11766126
[TBL] [Abstract][Full Text] [Related]
17. Biomechanical monitoring of cutaneous sulfur mustard-induced lesions in the weanling pig model for depth of injury.
Reid FM; Niemuth NA; Shumaker SM; Waugh JD; Graham JS
Skin Res Technol; 2007 May; 13(2):217-25. PubMed ID: 17374066
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive methods for determining lesion depth from vesicant exposure.
Braue EH; Graham JS; Doxzon BF; Hanssen KA; Lumpkin HL; Stevenson RS; Deckert RR; Dalal SJ; Mitcheltree LW
J Burn Care Res; 2007; 28(2):275-85. PubMed ID: 17351445
[TBL] [Abstract][Full Text] [Related]
19. Characterization of sulfur mustard vapor-induced cutaneous lesions on haired guinea pigs.
Braue EH; Nails CR; Way RA; Zallnick JE; Rieder RG; Lee RB; Mitcheltree LW
Skin Res Technol; 1998 May; 4(2):99-108. PubMed ID: 27332107
[TBL] [Abstract][Full Text] [Related]
20. Alterations in inflammatory cytokine gene expression in sulfur mustard-exposed mouse skin.
Sabourin CL; Petrali JP; Casillas RP
J Biochem Mol Toxicol; 2000; 14(6):291-302. PubMed ID: 11083082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
